Treatment of hepatitis C

Innovations used in antiviral therapy with hepatitis C, description of the main treatment, a list of patients with direct contraindications, side effects of treatment.

Content

• Reverse side of the medal of antiviral therapy
• Other preparations for the treatment of hepatitis with
• Contraindications for therapy against hepatitis with

Scattered myth that hepatitis with impossible to cure hepatitis. In a percentage of complete recovery, chronic hepatitis with confidently overtook chronic hepatitis in. International Analytics speaks of 80% of recovery with a properly selected treatment of hepatitis C, based on the results of analyzes, features of the body and the virus genotype.

Upon reaching a complete relief of viral reproduction in the liver, the intensity of inflammatory processes is significantly reduced, fibrosis does not progress. After therapy over the next year, in the absence of HCV-RNA in the blood, the patient is considered healthy, and the functionality of the liver resumes. If the course of therapy has not reached its result, the patient prescribe a re-treatment according to special schemes.

The issue of treating hepatitis C is engaged in a huge number of scientists. The effectiveness of existing methods is effective in 65% of patients. Apply combined antiviral therapy using interferon pegylated alpha preparations in combination with «Ribavian». There are no common generally accepted standards for treatment, it is prescribed strictly in the blood serum indicators, the level of the virus and changes in the liver tissue.

Therapy length — from 4 to 18 months, depending on the testimony and health status of the patient. The main criterion for successful treatment is persistent remission and reduced the level of some components in the blood.

US scientists offered their own option of therapy from viral hepatitis C: so far only for 1 genotype of 11. The proposed combination of drugs after tests led to a complete deliverance from the virus in 96% of patients.

In 2013, new drugs were tested in the CIS, with the help of which it was possible to achieve a positive result on average in 92% of patients. Medicines are created on the basis of protease inhibitors, which act on the hepatitis C virus, blocking its reproduction in the cell. The course of treatment on average is 3 months. The preparation of the last generation is «Viramidin», Which is an analogue «Ribavirin», Calling more «soft» side effects.

All these drugs were registered and went on sale, but their financial accessibility remains much to be desired.

It can significantly complicate the situation to join the existing hepatitis with other forms of viral hepatitis. Here in 97% of cases, the prognosis is unfavorable, the disease ends with a fatal outcome.

Reverse side of the medal of antiviral therapy

Should be ready and to some side effects of antiviral therapy, to which most patients are quickly adapted. Basic side manifestations when taking «Ribavirin»:

«Interferon» Can give such adverse reactions of the body as:

Other preparations for the treatment of hepatitis with

In addition to major drugs — «Alpha Interferon» and «Ribavirin», Apply additional drug therapy. This is necessarily hepatoprotectors, the action of which is aimed at maintaining and improving the functionality of the liver. Immunomodulators with weakened hepatitis with organism, providing more active organism resistance. Showing diet number 5 and alcohol failure. However, all treatment is purely individually and depends on many factors of the course of the disease and the general condition of the patient. Any self-treatment methods can aggravate the process.

Worse react to hepatitis treatment with male patients, which are more than forty years.

Contraindications for therapy against hepatitis with

There are a number of patients who have contraindications for therapy when hepatitis with. Some states or diseases available in the patient prevent full-fledged antiviral therapy. These patients include: